Back
Nuveen Real Estate Income Fund Vs. Moderna Industry Stock Comparison
Buy
69
JRS
Nuveen Real Estate Income Fund
Last Price:
$8.59
Seasonality Move:
0.46%
Sell
21
MRNA
Moderna
Last Price:
$42.42
Seasonality Move:
19.97%
Buy
69
Nuveen Real Estate Income Fund (JRS)
is a Buy
Is Nuveen Real Estate Income Fund a Buy, Sell or Hold?
-
The current Nuveen Real Estate Income Fund [JRS] share price is $8.57. The Score for JRS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
JRS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JRS Stock Price Chart
What is Nuveen Real Estate Income Fund's stock price today?
-
The Nuveen Real Estate Income Fund share price today is $8.57The current trend is relatively stagnant and JRS is experiencing selling pressure, which indicates risk of future bearish movement.
MRNA Stock Price Chart
JRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 48.45 | Sell |
Chaikin Money Flow: | -66125 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.3 - 8.7) | Buy |
Bollinger Bands (100): | (8.63 - 9.31) | Sell |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | -293401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.28 - 42.88) | Sell |
Bollinger Bands (100): | (39.14 - 65.28) | Sell |
JRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.43 | Buy |
20-day SMA: | 8.48 | Buy |
50-day SMA: | 8.92 | Sell |
200-day SMA: | 8.35 | Buy |
8-day EMA: | 8.51 | Buy |
20-day EMA: | 8.55 | Buy |
50-day EMA: | 8.74 | Sell |
200-day EMA: | 8.48 | Buy |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.11 | Buy |
20-day SMA: | 39.35 | Sell |
50-day SMA: | 40.91 | Sell |
200-day SMA: | 85.24 | Sell |
8-day EMA: | 36.96 | Buy |
20-day EMA: | 38.78 | Sell |
50-day EMA: | 43.4 | Sell |
200-day EMA: | 72.01 | Sell |
Nuveen Real Estate Income Fund Earnings Growth & JRS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $2.09 per share.
Nuveen Real Estate Income Fund Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |